HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ze-Long Liu Selected Research

Neutralizing Antibodies

1/2017Activation of STAT3-mediated CXCL12 up-regulation in the dorsal root ganglion contributes to oxaliplatin-induced chronic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ze-Long Liu Research Topics

Disease

4Neoplasms (Cancer)
11/2020 - 01/2017
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 11/2020
1Genomic Instability
11/2020
1Urethral Stricture
08/2020
1Abscess
08/2020
1Urinary Retention
08/2020
1Neoplasm Metastasis (Metastasis)
01/2020
1Microsatellite Instability
01/2020
1Cholangiocarcinoma
01/2020
1Nasopharyngeal Carcinoma
01/2018
1Breast Neoplasms (Breast Cancer)
01/2018
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2018
1Mucositis
01/2018
1Hyperalgesia
01/2017
1Chronic Pain
01/2017
1Painful Neuropathy
01/2017
1Hemophilia A (Haemophilia)
08/2010
1Inborn Genetic Diseases (Disease, Hereditary)
01/2010
1Cystic Fibrosis (Mucoviscidosis)
01/2010
1Leukemia
08/2006

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
11/2020 - 01/2020
1Immune Checkpoint InhibitorsIBA
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020
1RNA (Ribonucleic Acid)IBA
11/2020
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
11/2020
1Therapeutic UsesIBA
08/2020
1B7-H1 AntigenIBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Cetuximab (Erbitux)FDA Link
01/2018
1Monoclonal AntibodiesIBA
01/2018
1nimotuzumabIBA
01/2018
1E2F Transcription FactorsIBA
01/2018
1ErbB Receptors (EGF Receptor)IBA
01/2018
1Small Interfering RNA (siRNA)IBA
01/2017
1NSC 74859IBA
01/2017
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2017
1Neutralizing AntibodiesIBA
01/2017
1LigandsIBA
01/2017
1Proteins (Proteins, Gene)FDA Link
08/2010
1Factor VIII (Coagulation Factor VIII)IBA
08/2010
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
01/2010

Therapy/Procedure

4Therapeutics
01/2021 - 01/2018
2Radiotherapy
01/2020 - 01/2018
1Decompression
08/2020
1Catheters
08/2020
1Solid-State Lasers
08/2020
1Immunotherapy
01/2020
1Drug Therapy (Chemotherapy)
01/2020
1Chemoradiotherapy
01/2018
1Spinal Injections
01/2017
1Intravenous Injections
08/2006